JP2024540485A5 - - Google Patents
Info
- Publication number
- JP2024540485A5 JP2024540485A5 JP2024529343A JP2024529343A JP2024540485A5 JP 2024540485 A5 JP2024540485 A5 JP 2024540485A5 JP 2024529343 A JP2024529343 A JP 2024529343A JP 2024529343 A JP2024529343 A JP 2024529343A JP 2024540485 A5 JP2024540485 A5 JP 2024540485A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- compound
- membered heterocycles
- carbon rings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163280457P | 2021-11-17 | 2021-11-17 | |
| US63/280,457 | 2021-11-17 | ||
| PCT/US2022/050313 WO2023091606A1 (en) | 2021-11-17 | 2022-11-17 | Pyridazinone compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540485A JP2024540485A (ja) | 2024-10-31 |
| JP2024540485A5 true JP2024540485A5 (cg-RX-API-DMAC7.html) | 2025-11-25 |
Family
ID=84519449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529343A Pending JP2024540485A (ja) | 2021-11-17 | 2022-11-17 | ピリダジノン化合物およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240336609A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433473A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540485A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023091606A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2958954T3 (es) | 2018-11-06 | 2024-02-16 | Edgewise Therapeutics Inc | Compuestos de piridazinona y usos de los mismos |
| WO2020097258A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP3877052B1 (en) | 2018-11-06 | 2023-08-16 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4149620B1 (en) * | 2020-05-13 | 2024-10-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2293638T3 (es) | 1994-03-25 | 2008-03-16 | Isotechnika, Inc. | Mejora de la eficacia de farmacos por deuteracion. |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007032507A1 (de) * | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
| TWI829634B (zh) * | 2017-04-06 | 2024-01-21 | 美商富曼西公司 | 殺真菌之噁二唑 |
| ES2958954T3 (es) * | 2018-11-06 | 2024-02-16 | Edgewise Therapeutics Inc | Compuestos de piridazinona y usos de los mismos |
| EP3877052B1 (en) * | 2018-11-06 | 2023-08-16 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4149620B1 (en) * | 2020-05-13 | 2024-10-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
-
2022
- 2022-11-17 EP EP22823233.6A patent/EP4433473A1/en active Pending
- 2022-11-17 WO PCT/US2022/050313 patent/WO2023091606A1/en not_active Ceased
- 2022-11-17 JP JP2024529343A patent/JP2024540485A/ja active Pending
-
2024
- 2024-05-16 US US18/666,699 patent/US20240336609A1/en active Pending